HETEROGENEOUS TUMOR RESPONSE TO PHOTODYNAMIC THERAPY ASSESSED BY INVIVO LOCALIZED P-31 NMR-SPECTROSCOPY

被引:15
|
作者
CECKLER, TL
GIBSON, SL
KENNEDY, SD
HILF, R
BRYANT, RG
机构
[1] UNIV ROCHESTER,SCH MED & DENT,DEPT BIOCHEM,BOX 607,601 ELMWOOD AVE,ROCHESTER,NY 14642
[2] UNIV ROCHESTER,SCH MED & DENT,DEPT BIOPHYS,ROCHESTER,NY 14642
[3] UNIV ROCHESTER,SCH MED & DENT,CTR CANC,ROCHESTER,NY 14642
关键词
D O I
10.1038/bjc.1991.201
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Photodynamic therapy (PDT) is efficacious in the treatment of small malignant lesions when all cells in the tumour receive sufficient drug, oxygen and light to induce a photodynamic effect capable of complete cytotoxicity. In large tumours, only partial effectiveness is observed presumably because of insufficient light penetration into the tissue. The heterogeneity of the metabolic response in mammary tumours following PDT has been followed in vivo using localised phosphorus NMR spectroscopy. Alterations in nucleoside triphosphates (NTP), inorganic phosphate (P(i)) and pH within localised regions of the tumour were monitored over 24-48 h following PDT irradiation of the tumour. Reduction of NTP and increases in P(i) were observed at 4-6 h after PDT irradiation in all regions of treated tumours. The uppermost regions of the tumours (those nearest the skin surface and exposed to the greatest light fluence) displayed the greatest and most prolonged reduction of NTP and concomitant increase in P(i) resulting in necrosis. The metabolite concentrations in tumour regions located towards the base of the tumour returned to near pre-treatment levels by 24-48 h after irradiation. The ability to follow heterogeneous metabolic responses in situ provides one means to assess the degree of metabolic inhibition which subsequently leads to tumour necrosis.
引用
收藏
页码:916 / 922
页数:7
相关论文
共 50 条
  • [31] P-31 NMR-SPECTROSCOPY IN CHRONIC ADRIAMYCIN CARDIOTOXICITY
    BITTNER, V
    REEVES, RC
    DIGERNESS, SB
    CAULFIELD, JB
    POHOST, GM
    MAGNETIC RESONANCE IN MEDICINE, 1991, 17 (01) : 69 - 81
  • [32] P-31 NMR-SPECTROSCOPY IN MULTIPLE-SCLEROSIS
    MOOYAART, EL
    KAMMAN, RL
    HOOGSTRATEN, MC
    GRAVENMADE, EJS
    MINDERHOUD, JM
    RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY, 1989, 863 : 285 - 286
  • [33] P-31 NMR-SPECTROSCOPY IN MYOTONIC-DYSTROPHY
    KAMINSKY, P
    WALKER, P
    ROBINLHERBIER, B
    FENER, P
    ESCANYE, JM
    POUREL, J
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 203 - 203
  • [34] P-31 NMR-SPECTROSCOPY OF SOLID PHOSPHORUS SULFIDES
    DEMARCQ, MC
    JOURNAL OF PHYSICAL CHEMISTRY, 1990, 94 (16): : 6514 - 6515
  • [35] P-31 NMR-SPECTROSCOPY OF HUMAN-PLACENTA
    GORDON, JD
    KAY, HH
    SPICER, LD
    INVESTIGATIVE RADIOLOGY, 1988, 23 (09) : S63 - S63
  • [36] THE APPLICATION OF DEPTH-PULSE LOCALIZED P-31 NMR-SPECTROSCOPY TO MONITOR TUMOR METABOLISM AND RESPONSE TO CHEMOTHERAPY IN THE RAT-KIDNEY
    STEWART, CA
    HANSTOCK, CC
    ALLEN, PS
    MAGNETIC RESONANCE IN MEDICINE, 1988, 7 (01) : 100 - 110
  • [37] P-31 NMR-SPECTROSCOPY OF LIVING TOAD RETINAE
    APTE, DV
    KOUTALOS, Y
    MCFARLANE, DK
    DAWSON, MJ
    EBREY, TG
    BIOPHYSICAL JOURNAL, 1988, 53 (02) : A387 - A387
  • [38] STUDY OF THE METABOLIC MYOPATHIES BY NMR-SPECTROSCOPY OF P-31
    JEHENSON, P
    DUBOC, D
    DINH, ST
    SYROTA, A
    JOURNAL DE BIOPHYSIQUE ET DE BIOMECANIQUE, 1986, 10 (04): : 183 - 185
  • [39] P-31 NMR-SPECTROSCOPY OF ISOLATED PERFUSED LUNGS
    PILLAI, RP
    BUESCHER, PC
    PEARSE, DB
    SYLVESTER, JT
    EICHHORN, GL
    MAGNETIC RESONANCE IN MEDICINE, 1986, 3 (03) : 467 - 472
  • [40] P-31 NMR-SPECTROSCOPY OF PHOSPHORUS SULFUR GLASSES
    DEMARCQ, MC
    JOURNAL OF PHYSICAL CHEMISTRY, 1990, 94 (18): : 7330 - 7330